Business Context and Reporting Period
Company: Beyond Meat, Inc. (BYND)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 29, 2024
Overview: Beyond Meat is a leading plant-based meat company. The period reflects continued execution of a "Global Operations Review" initiated in November 2023, focusing on cost reduction, inventory management, and narrowing commercial focus. The company discontinued the Beyond Meat Jerky product line in 2023.
Key Financial Metrics
| Metric (in thousands) | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Net Revenues | $93,185 | $102,149 | $168,788 | $194,385 |
| Gross Profit | $13,717 | $2,273 | $17,385 | $8,458 |
| Gross Margin | 14.7% | 2.2% | 10.3% | 4.4% |
| Operating Loss | $(33,931) | $(53,754) | $(87,405) | $(111,475) |
| Net Loss | $(34,479) | $(53,505) | $(88,840) | $(112,542) |
| Diluted EPS | $(0.53) | $(0.83) | $(1.37) | $(1.76) |
| Cash & Equivalents (End of Period) | $144,873 | Balance Sheet Data | ||
| Restricted Cash | $13,136 | Balance Sheet Data | ||
| Convertible Senior Notes (Net) | $1,139,509 | Balance Sheet Data | ||
| Net Cash Used in Operating Activities (YTD) | $(47,814) | $(88,336) | Cash Flow Data |
Material Changes vs. Prior Period
- Revenue Decline: Net revenues decreased 8.8% in Q2 and 13.2% YTD compared to the prior year, driven primarily by a 14.0% (Q2) and 15.0% (YTD) decrease in volume sold due to weak category demand and the discontinuation of the Jerky line. This was partially offset by a 6.1% (Q2) and 2.0% (YTD) increase in net revenue per pound due to price increases and lower trade discounts.
- Margin Expansion: Gross margin improved significantly to 14.7% in Q2 (from 2.2% in Q2 2023) and 10.3% YTD (from 4.4% YTD 2023). Improvements were driven by lower cost of goods sold per pound (reduced inventory provisions, lower manufacturing/logistics costs) and higher net revenue per pound.
- Expense Reduction: Operating expenses decreased due to workforce reductions implemented in late 2023. R&D expenses fell 37.5% in Q2, and SG&A expenses fell 11.2% in Q2. However, YTD SG&A included a $7.5 million charge for a consumer class action settlement.
- Loss Narrowing: Net loss decreased 35.5% in Q2 and 21.0% YTD compared to the prior year periods, reflecting the combined impact of margin expansion and operating expense reductions.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management believes existing cash balances and anticipated cash flow will be sufficient to meet requirements for at least the next twelve months. The company anticipates seeking additional capital in 2024, potentially via the ATM Program (up to $200 million available) or debt/equity issuance.
- Unusual Items:
- Settlement Charge: A $7.5 million charge was recorded in SG&A for a settlement of consumer class action lawsuits regarding protein claims. Payment is expected to be $0.25 million in 2024 and $7.25 million in 2025.
- Foreign Currency: Net realized and unrealized foreign currency transaction losses were $1.2 million in Q2 and $3.5 million YTD, impacting "Other, net" income.
- Key Risks:
- Regulatory: Ongoing litigation in France and the EU regarding the use of "meat" names for plant-based products (Contested Decree). A ruling by the Court of Justice of the European Union (CJEU) is expected later in 2024.
- Liquidity: Dependence on capital markets for future funding; potential inability to raise capital on favorable terms.
- Operations: Risks related to the build-out and occupancy of the Campus Headquarters in El Segundo, CA, including potential impairment charges if subleasing is not successful.
- Supply Chain: Exposure to raw material price volatility (pea protein) and supply chain disruptions.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $158 million total cash position against the $1.15 billion convertible note principal due in 2027 and ongoing operating losses.
- Settlement Impact: Confirm the timing and final approval of the $7.5 million class action settlement and its impact on 2025 cash flows.
- Regulatory Precedent: Monitor the CJEU ruling on the French "meat names" ban, which could impact product labeling and sales across the EU.
- Volume vs. Price: Assess whether price increases can sustainably offset the structural decline in sales volume (down 14-15% YTD) in a competitive market.
- ATM Program: Track any utilization of the $200 million "at-the-market" equity offering program, which could result in shareholder dilution.